ARCHIVES

Long-Term Effect Of One Phase III Trial: Benefit For Thousands Of Patients

This article is from The Cancer Letter archive.

Vol. 32 No. 11 | November 27, 2009

Download PDF Visit The Full Archive

Related Articles

Five Advocates Named To SWOG Committees; NCI, NASA Sign Nanotechnology Agreement.

April 21, 2000

Intensity Modulated Therapy Safer Than Three-Dimensional Radiation

June 24, 2011

In Brief: Community Outreach Planning Grants Still Open; Study Section Meetings May Be Opened By Courts

October 18, 1974

Amgen Halts Phase III Trial Of Ganitumab Plus Gemcitabine

August 31, 2012

Senate Appropriations Committee Slashes NCI Funds By $25 Million

August 18, 1978

Committee Recommends FDA Approval Of Three New Drugs For Cancer Treatment

March 27, 1998